- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about SNY
Recent news which mentions SNY
From Benzinga
From Benzinga
Coinbase’ stock tumbles on SEC warning, while First Republic and Regeneron shares rally, and other stocks on the move
March 23, 2023
From MarketWatch
From Benzinga
Large Vaccine Players Including GSK, Moderna Prepare For Bird Flu Vaccine 'Just In Case'
March 20, 2023
From Benzinga
From Benzinga
From Benzinga
Three Is Company - Sanofi Follows Lilly, Novo Nordisk, Slashes Insulin Product Price By 78%
March 17, 2023
From Benzinga
Why Provention Bio Stock Skyrocketed 256% This Week
March 16, 2023
From Motley Fool
2 Top Biotech Stocks to Buy Right Now
March 15, 2023
From Motley Fool
From Motley Fool
From Benzinga
From Benzinga
Why Is Provention Bio (PRVB) Stock Up 263% Today?
March 13, 2023
From InvestorPlace
From InvestorPlace
Nasdaq Futures Climb Solidly After Past Week's Rout: Analyst Flags Key S&P 500 Support To Stay Above October Lows
March 13, 2023
From Benzinga
7 Blue-Chip Stocks to Buy for Quality-Focused Investors
March 06, 2023
From InvestorPlace
From Motley Fool
Eli Lilly CEO says $35 for monthly insulin ‘should be the new standard in America’ — and experts say that could happen
March 01, 2023
From MarketWatch
FDA Approves Regeneron-Sanofi's Sarilumab As First Biologic For Stiffness, Pain In Muscles
March 01, 2023
From Benzinga
From Benzinga
This chart gives one reason European stocks may continue to outperform U.S. equities
February 17, 2023
From MarketWatch
BioRestorative (NASDAQ: BRTX) Ramps Up Production In Anticipation Of Positive Phase 2 Results
February 03, 2023
From Benzinga
Nasdaq Futures Deflate As Apple Leads Tech Disappointments: Traders Look To Jobs Data For Mitigating Impact
February 03, 2023
From Benzinga
Sanofi Expects Moderate 2023 Profit Growth On Dupixent Demand, But Dampened By Aubagio Generics Competition
February 03, 2023
Tickers
SNY
From Benzinga
Alphabet, Apple And 3 Stocks To Watch Heading Into Friday
February 03, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.